SIM
ZVRA icon

Spark Investment Management’s Zevra Therapeutics ZVRA Stock Holding History

Spark Investment Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,237
Closed -$86K – 719
2019
Q1 		$86K Hold
3,237
– – ﹤0.01% 586
2018
Q4 		$92K Buy
+3,237
New +$131K 0.01% 570
2018
Q3 		– Sell
-1,694
Closed -$176K – 753
2018
Q2 		$176K Buy
+1,694
New +$165K 0.01% 570
2018
Q1 		– Sell
-944
Closed -$61K – 742
2017
Q4 		$61K Sell
944
-237
-20% -$14.3K ﹤0.01% 652
2017
Q3 		$69K Sell
1,181
-263
-18% -$14K ﹤0.01% 682
2017
Q2 		$92K Buy
+1,444
New +$95.1K 0.01% 726
2016
Q4 		– Sell
-1,881
Closed -$135K – 891
2016
Q3 		$135K Sell
1,881
-6,938
-79% -$494K 0.01% 723
2016
Q2 		$561K Buy
8,819
+5,830
+195% +$959K 0.05% 441
2016
Q1 		$693K Buy
2,989
+1,764
+144% +$427K 0.07% 373
2015
Q4 		$389K Buy
1,225
+25
+2% +$6.79K 0.05% 423
2015
Q3 		$371K Buy
+1,200
New +$367K 0.05% 430

Other funds holding ZVRA

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Spark Investment Management's ZVRA Position: Q2 2019 in Review

Spark Investment Management sold out of Zevra Therapeutics (ZVRA) in Q2 2019, closing a stake of 3,237 shares — an estimated $86K sold.

Spark Investment Management first reported a position in ZVRA in Q3 2015 and held it in 11 quarters. The position peaked at $693K in Q1 2016. 32 funds tracked by Wall St. Rank hold ZVRA as of Q2 2019.

  • Spark Investment Management reported no remaining Zevra Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Spark Investment Management sold 3,237 Zevra Therapeutics shares in Q2 2019, an estimated $86K.
  • Spark Investment Management first reported a position in Zevra Therapeutics in Q3 2015 and held it in 11 quarters.
  • Spark Investment Management's Zevra Therapeutics position peaked at $693K in Q1 2016.
  • 32 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2019.

Based on Spark Investment Management's 13F filing for Q2 2019, filed 12 Aug 2019.